Automatic Web Traffic Generator
Cart Cell Therapy: Will First To Market Mean First To Disappoint | AutoTraffic
TapImmune, Inc. (TPIV) CEO Peter Hoang on the Proposed Merger with Marker Therapeutics Transcript
When we think about cell therapies today, you all know that cell therapies are captured in enormous amount of market ... first dosed patients at Baylor College of Medicine using this therapy back in 2... read more
The Immune System Fights Back
The first inkling came ... so-called exhaustion markers on T cells to understand what they mean for the potency of a cell-based immunotherapy. While companies sort out the nuances of bringing CARTs fo... read more
Interviewing Def Leppard guitarist Vivian Campbell: Band, coming to Allentown Fair, hopes to be 're-adrenalized' by new disc
“I mean, I’m feeling fine ... “But I’ve managed to schedule it all, so I missed the first four shows of the American tour because I was dealing with the whole radiation/therapy bit and it’s good. It’s ... read more
Will Agenus (AGEN) Disappoint Investors This Earnings Season?
Agenus Inc. AGEN is expected to report first ... a product to market. Any hiccup in the development process of these candidates may weigh on the stock. In October 2017, Agenus established a separate b... read more
What will separate the winners and the losers in the immuno-oncology R&D race?
It’s been only five years since the first checkpoint inhibitor ... don’t capture the “other” I/O settings – like chimeric antigen receptor T-cell therapy (CART), where a dozen or more programs are in ... read more
Will Personalized Medicine Mean Higher Costs for Consumers?
In the employer market, increasing pressures to cut labor costs ... of-pocket drug costs and limits on insurers’ ability to use prior authorization and step therapy requirements to create barriers to ... read more
CytoDyn And HIV Therapy: CCR5 Antagonist Is An Old Drug Made New
HIV/AIDS is associated with the loss of CD4(+) T cells ... for HIV therapy. In my humble opinion, the breakthrough really began with the discovery of CCR5 and CCXR4 as portals for HIV infection. A sub... read more
Top Trends in Biopharmaceutical Manufacturing: 2015
New cell-culture techniques, biomanufacturing formats, biological products, and the expansion of single-use applications are driving rapid change in the biopharmaceutical market ... Monge stresses. Th... read more
New Cystic Fibrosis Medication a Triumph of Drug Discovery
Getting a drug from conception to market is among the riskiest ... possible for the cost of the combination therapy to actually be lesser than that of ivacaftor alone. It's still not cheap, but consid... read more
The Flying Car That Could Expedite Your Morning Commute
Flying cars have long been the unofficial signpost that will mark ... The U.S. Patent Office in 1918 issued Felix Longobardi the first patent for a flying vehicle, which was also submersible in water. ... read more
Subscribe to RSS Feed
Celgene Shareholders Excited by CAR-T News
More From The Motley Fool Kristine Harjes: So, we got some very exciting news from several different CAR-T developers at ASH, but the first one ... we'll get on the market faster, then we can conduct ... read more
Buy AutoTrafficRSS script now for only $27!
We will send the script to your PayPal email within few hours,
Please add FullContentRSS@gmail.com to your email contact.